Italia markets close in 7 hours 7 minutes
FTSE MIB
34.247,70 -23,42 (-0,07%) Dow Jones
38.460,92 -42,77 (-0,11%) Nasdaq
15.712,75 +16,11 (+0,10%) Nikkei 225
37.628,48 -831,60 (-2,16%) Petrolio
83,21 +0,40 (+0,48%) Bitcoin EUR
59.820,49 -2.335,75 (-3,76%)
DaVita Inc. (0I7E.L)
LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 06:57PM BST. Mercato aperto.
| Chiusura precedente | 134,11 |
| Aperto | 0,00 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 1.554 |
| Capitalizzazione | 224,698M |
| Beta (5 anni mensile) | 1,05 |
| Rapporto PE (ttm) | 0,16 |
| EPS (ttm) | 8,46 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.